67 related articles for article (PubMed ID: 23026372)
1. Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone.
Suzuki S; Kurata Y; Li P; Notsu T; Hasegawa A; Ikeda N; Kato M; Miake J; Sakata S; Shiota G; Yoshida A; Ninomiya H; Higaki K; Yamamoto K; Shirayoshi Y; Hisatome I
Eur J Pharmacol; 2012 Dec; 696(1-3):28-34. PubMed ID: 23026372
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of Kv1.5 channel protein by the inotropic agent olprinone.
Endo R; Kurata Y; Notsu T; Li P; Morikawa K; Kondo T; Ogura K; Miake J; Yoshida A; Shirayoshi Y; Ninomiya H; Higaki K; Kuwabara M; Yamamoto K; Inagaki Y; Hisatome I
Eur J Pharmacol; 2015 Oct; 765():488-94. PubMed ID: 26368666
[TBL] [Abstract][Full Text] [Related]
3. Functional stabilization of Kv1.5 protein by Hsp70 in mammalian cell lines.
Hirota Y; Kurata Y; Kato M; Notsu T; Koshida S; Inoue T; Kawata Y; Miake J; Bahrudin U; Li P; Hoshikawa Y; Yamamoto Y; Igawa O; Shirayoshi Y; Nakai A; Ninomiya H; Higaki K; Hiraoka M; Hisatome I
Biochem Biophys Res Commun; 2008 Aug; 372(3):469-74. PubMed ID: 18502196
[TBL] [Abstract][Full Text] [Related]
4. Stabilizing effects of eicosapentaenoic acid on Kv1.5 channel protein expressed in mammalian cells.
Koshida S; Kurata Y; Notsu T; Hirota Y; Kuang TY; Li P; Bahrudin U; Harada S; Miake J; Yamamoto Y; Hoshikawa Y; Igawa O; Higaki K; Soma M; Yoshida A; Ninomiya H; Shiota G; Shirayoshi Y; Hisatome I
Eur J Pharmacol; 2009 Feb; 604(1-3):93-102. PubMed ID: 19121632
[TBL] [Abstract][Full Text] [Related]
5. Evidence for proteasomal degradation of Kv1.5 channel protein.
Kato M; Ogura K; Miake J; Sasaki N; Taniguchi S; Igawa O; Yoshida A; Hoshikawa Y; Murata M; Nanba E; Kurata Y; Kawata Y; Ninomiya H; Morisaki T; Kitakaze M; Hisatome I
Biochem Biophys Res Commun; 2005 Nov; 337(1):343-8. PubMed ID: 16185660
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of bepridil on hKv1.5 channel current: comparison with amiodarone and E-4031.
Kobayashi S; Reien Y; Ogura T; Saito T; Masuda Y; Nakaya H
Eur J Pharmacol; 2001 Nov; 430(2-3):149-57. PubMed ID: 11711026
[TBL] [Abstract][Full Text] [Related]
7. Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection.
Sato T; Costa AD; Saito T; Ogura T; Ishida H; Garlid KD; Nakaya H
J Pharmacol Exp Ther; 2006 Jan; 316(1):182-8. PubMed ID: 16174795
[TBL] [Abstract][Full Text] [Related]
8. Long-term 4-AP treatment facilitates functional expression of human Kv1.5 channel.
Xie Y; Ding WG; Liu Y; Yu M; Sun X; Matsuura H
Eur J Pharmacol; 2019 Feb; 844():195-203. PubMed ID: 30552904
[TBL] [Abstract][Full Text] [Related]
9. Oxyhemoglobin-induced suppression of voltage-dependent K+ channels in cerebral arteries by enhanced tyrosine kinase activity.
Ishiguro M; Morielli AD; Zvarova K; Tranmer BI; Penar PL; Wellman GC
Circ Res; 2006 Nov; 99(11):1252-60. PubMed ID: 17068294
[TBL] [Abstract][Full Text] [Related]
10. The Kv1.3 potassium channel is localized to the cis-Golgi and Kv1.6 is localized to the endoplasmic reticulum in rat astrocytes.
Zhu J; Yan J; Thornhill WB
FEBS J; 2014 Aug; 281(15):3433-45. PubMed ID: 24924920
[TBL] [Abstract][Full Text] [Related]
11. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
Remillard CV; Tigno DD; Platoshyn O; Burg ED; Brevnova EE; Conger D; Nicholson A; Rana BK; Channick RN; Rubin LJ; O'connor DT; Yuan JX
Am J Physiol Cell Physiol; 2007 May; 292(5):C1837-53. PubMed ID: 17267549
[TBL] [Abstract][Full Text] [Related]
12. Proteasomal degradation of Kir6.2 channel protein and its inhibition by a Na+ channel blocker aprindine.
Tanaka H; Miake J; Notsu T; Sonyama K; Sasaki N; Iitsuka K; Kato M; Taniguchi S; Igawa O; Yoshida A; Shigemasa C; Hoshikawa Y; Kurata Y; Kuniyasu A; Nakayama H; Inagaki N; Nanba E; Shiota G; Morisaki T; Ninomiya H; Kitakaze M; Hisatome I
Biochem Biophys Res Commun; 2005 Jun; 331(4):1001-6. PubMed ID: 15882977
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
[TBL] [Abstract][Full Text] [Related]
14. Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter.
Plane F; Johnson R; Kerr P; Wiehler W; Thorneloe K; Ishii K; Chen T; Cole W
Circ Res; 2005 Feb; 96(2):216-24. PubMed ID: 15618540
[TBL] [Abstract][Full Text] [Related]
15. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
Lagrutta A; Wang J; Fermini B; Salata JJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
[TBL] [Abstract][Full Text] [Related]
16. A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus.
Corzo G; Papp F; Varga Z; Barraza O; Espino-Solis PG; Rodríguez de la Vega RC; Gaspar R; Panyi G; Possani LD
Biochem Pharmacol; 2008 Oct; 76(9):1142-54. PubMed ID: 18786511
[TBL] [Abstract][Full Text] [Related]
17. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.
Fedida D; Eldstrom J; Hesketh JC; Lamorgese M; Castel L; Steele DF; Van Wagoner DR
Circ Res; 2003 Oct; 93(8):744-51. PubMed ID: 14500335
[TBL] [Abstract][Full Text] [Related]
18. Expression of voltage-gated K+ channels in human atrium.
Bertaso F; Sharpe CC; Hendry BM; James AF
Basic Res Cardiol; 2002 Nov; 97(6):424-33. PubMed ID: 12395204
[TBL] [Abstract][Full Text] [Related]
19. KCNE4 suppresses Kv1.3 currents by modulating trafficking, surface expression and channel gating.
Solé L; Roura-Ferrer M; Pérez-Verdaguer M; Oliveras A; Calvo M; Fernández-Fernández JM; Felipe A
J Cell Sci; 2009 Oct; 122(Pt 20):3738-48. PubMed ID: 19773357
[TBL] [Abstract][Full Text] [Related]
20. Effects of protein kinase C on delayed rectifier K+ channel regulation by tyrosine kinase in rat retinal pigment epithelial cells.
Strauss O; Rosenthal R; Dey D; Beninde J; Wollmann G; Thieme H; Wiederholt M
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1645-54. PubMed ID: 11980886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
